Adjuvant effects on morphine-induced suppression of immune responses to MN rgp120/HIV-1 in mice.
Virsik
P A
PA
Department of Pathobiology and Toxicology, Genentech, Inc., South San Francisco, California 94080, USA.
Bussiere
J L
JL
D000818:Animals; D005260:Female; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D006433:Hemocyanins / Q000276:immunology; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000494:pharmacology; D051379:Mice; D008809:Mice, Inbred C3H; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology
D015699:HIV Envelope Protein gp120; D007166:Immunosuppressive Agents; D009270:Naloxone; D009020:Morphine; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin